HighVista Strategies’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$898K Sell
1,514
-816
-35% -$406K 0.25% 120
2025
Q4
$1.14M Buy
+2,330
New +$1.09M 0.29% 99
2024
Q3
Sell
-1,409
Closed -$449K 170
2024
Q2
$449K Buy
+1,409
New +$373K 0.16% 118
2024
Q1
Sell
-2,299
Closed -$506K 156
2023
Q4
$506K Hold
2,299
0.18% 118
2023
Q3
$519K Buy
2,299
+557
+32% +$128K 0.24% 105
2023
Q2
$385K Sell
1,742
-1,462
-46% -$324K 0.18% 128
2023
Q1
$718K Hold
3,204
0.58% 58
2022
Q4
$891K Sell
3,204
-662
-17% -$167K 0.53% 54
2022
Q3
$809K Buy
3,866
+414
+12% +$92.6K 0.46% 57
2022
Q2
$813K Buy
3,452
+795
+30% +$162K 0.49% 45
2022
Q1
$477K Sell
2,657
-3,609
-58% -$688K 0.3% 73
2021
Q4
$1.35M Buy
6,266
+362
+6% +$71.1K 1.08% 28
2021
Q3
$1.09M Buy
+5,904
New +$1.16M 0.72% 47

Other funds holding UTHR